Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All miscellaneous studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

Recent:   

Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial

Reis et al., The American Journal of Clinical Nutrition, doi:10.1016/j.ajcnut.2024.06.016
Aug 2024  
  Post
  Facebook
Share
  Source   PDF  
Hospitalization or ER>6 h.. -24% Improvement Relative Risk ER -21% Spirulina  Reis et al.  EARLY TREATMENT  RCT Is early treatment with spirulina beneficial for COVID-19? RCT in Brazil Higher progression with spirulina (not stat. sig., p=0.29) c19early.org Reis et al., The American J. Clinical .., Aug 2024 Favorsspirulina Favorscontrol 0 0.5 1 1.5 2+
RCT 1,126 patients in Brazil showing no significant differences with low dose spirulina. The dose used was 7.6 times lower than the dose used by Aghasadeghi et al. which shows significantly lower mortality.
hospitalization or ER>6 hours, 24.0% higher, OR 1.24, p = 0.29, RR approximated with OR.
ER, 21.0% higher, OR 1.21, p = 0.37, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Reis et al., 15 Aug 2024, Randomized Controlled Trial, placebo-controlled, Brazil, peer-reviewed, median age 49.0, 22 authors.
This PaperMiscellaneousAll
{ 'indexed': {'date-parts': [[2024, 8, 16]], 'date-time': '2024-08-16T00:26:03Z', 'timestamp': 1723767963117}, 'reference-count': 21, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2024, 8, 1]], 'date-time': '2024-08-01T00:00:00Z', 'timestamp': 1722470400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2024, 8, 1]], 'date-time': '2024-08-01T00:00:00Z', 'timestamp': 1722470400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/legal/tdmrep-license'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 8]]}, 'DOI': '10.1016/j.ajcnut.2024.06.016', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 15]], 'date-time': '2024-08-15T19:49:06Z', 'timestamp': 1723751346000}, 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER ' 'randomized trial', 'prefix': '10.1016', 'author': [ {'given': 'Gilmar', 'family': 'Reis', 'sequence': 'first', 'affiliation': []}, { 'given': 'Eduardo', 'family': 'Augusto dos Santos Moreira Silva', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Daniela', 'family': 'Carla Medeiros Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lehana', 'family': 'Thabane', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thiago', 'family': 'Santiago Ferreira', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Castilho', 'family': 'Vitor Quirino dos Santos', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Ana', 'family': 'Paula Figueiredo Guimaraes Almeida', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Leonardo', 'family': 'Cançado Monteiro Savassi', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Adhemar', 'family': 'Dias de Figueiredo Neto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luiza', 'family': 'Lanna França Reis', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Vitoria', 'family': 'Helena de Souza Campos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carina', 'family': 'Bitarães', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eduardo', 'family': 'Diniz Callegari', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Maria', 'family': 'Izabel Campos Simplicio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luciene', 'family': 'Barra Ribeiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rosemary', 'family': 'Oliveira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ofir', 'family': 'Harari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jamie I', 'family': 'Forrest', 'sequence': 'additional', 'affiliation': []}, {'given': 'Prince Kumar', 'family': 'Lat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Louis', 'family': 'Dron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristian', 'family': 'Thorlund', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edward J', 'family': 'Mills', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ajcnut.2024.06.016_bib1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.nut.2020.111089', 'article-title': 'Prospective options of algae-derived nutraceuticals as supplements to ' 'combat COVID-19 and human coronavirus diseases', 'volume': '83', 'author': 'Ratha', 'year': '2021', 'journal-title': 'Nutrition'}, { 'issue': '3', 'key': '10.1016/j.ajcnut.2024.06.016_bib2', 'doi-asserted-by': 'crossref', 'first-page': '248', 'DOI': '10.1038/cmi.2010.76', 'article-title': 'The effects of spirulina on anemia and immune function in senior ' 'citizens', 'volume': '8', 'author': 'Selmi', 'year': '2011', 'journal-title': 'Cell. Mol. Immunol.'}, { 'issue': '4', 'key': '10.1016/j.ajcnut.2024.06.016_bib3', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1016/S1567-5769(01)00166-7', 'article-title': 'Activation of the human innate immune system by spirulina: augmentation ' 'of interferon production and NK cytotoxicity by oral administration of ' 'hot water extract of Spirulina platensis', 'volume': '2', 'author': 'Hirahashi', 'year': '2002', 'journal-title': 'Int. Immunopharmacol.'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib4', 'article-title': 'Chemical and biological characterization of spirulina protein ' 'hydrolysates: focus on ACE and DPP-IV activities modulation', 'volume': '63', 'author': 'Aiello', 'year': '2019', 'journal-title': 'J.\xa0Funct. Foods.'}, { 'issue': '1', 'key': '10.1016/j.ajcnut.2024.06.016_bib5', 'doi-asserted-by': 'crossref', 'first-page': '2075', 'DOI': '10.1038/s41598-020-58896-6', 'article-title': 'Spirulina maxima extract prevents activation of the NLRP3 inflammasome ' 'by inhibiting ERK signaling', 'volume': '10', 'author': 'Chei', 'year': '2020', 'journal-title': 'Sci. Rep.'}, { 'issue': '1', 'key': '10.1016/j.ajcnut.2024.06.016_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41598-022-22148-6', 'article-title': 'In vitro inhibition of SARS-CoV-2 infection by dry algae powders', 'volume': '12', 'author': 'Garcia-Ruiz', 'year': '2022', 'journal-title': 'Sci. Rep.'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib7', 'series-title': 'The effects of Spirulina platensis supplementation on COVID-19 severity ' 'in critically ill patients: a randomized clinical trial', 'author': 'Javid', 'year': '2022'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib8', 'doi-asserted-by': 'crossref', 'first-page': '117', 'DOI': '10.12688/gatesopenres.13304.2', 'article-title': 'A\xa0multi-center, adaptive, randomized, platform trial to evaluate the ' 'effect of repurposed medicines in outpatients with early coronavirus ' 'disease 2019 (COVID-19) and high-risk for complications: the TOGETHER ' 'master trial protocol', 'volume': '5', 'author': 'Reis', 'year': '2021', 'journal-title': 'Gates Open Res'}, { 'issue': '1', 'key': '10.1016/j.ajcnut.2024.06.016_bib9', 'doi-asserted-by': 'crossref', 'first-page': 'e42', 'DOI': '10.1016/S2214-109X(21)00448-4', 'article-title': 'Effect of early treatment with fluvoxamine on risk of emergency care ' 'and hospitalisation among patients with COVID-19: the TOGETHER ' 'randomised, platform clinical trial', 'volume': '10', 'author': 'Reis', 'year': '2022', 'journal-title': 'Lancet Glob. Health'}, { 'issue': '4', 'key': '10.1016/j.ajcnut.2024.06.016_bib10', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2021.6468', 'article-title': 'Effect of early treatment with hydroxychloroquine or lopinavir and ' 'ritonavir on risk of hospitalization among patients with COVID-19: the ' 'TOGETHER randomized clinical trial', 'volume': '4', 'author': 'Reis', 'year': '2021', 'journal-title': 'JAMA Netw. Open'}, { 'issue': '18', 'key': '10.1016/j.ajcnut.2024.06.016_bib11', 'doi-asserted-by': 'crossref', 'first-page': '1721', 'DOI': '10.1056/NEJMoa2115869', 'article-title': 'Effect of early treatment with ivermectin among patients with COVID-19', 'volume': '386', 'author': 'Reis', 'year': '2022', 'journal-title': 'N.\xa0Engl. J. Med.'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib12', 'article-title': 'Effect of early treatment with metformin on risk of emergency care and ' 'hospitalization among patients with COVID-19: the TOGETHER randomized ' 'platform clinical trial', 'volume': '6', 'author': 'Reis', 'year': '2022', 'journal-title': 'Lancet Reg. Health Am'}, { 'issue': '8', 'key': '10.1016/j.ajcnut.2024.06.016_bib13', 'doi-asserted-by': 'crossref', 'first-page': 'e192', 'DOI': '10.1016/S1473-3099(20)30483-7', 'article-title': 'A\xa0minimal common outcome measure set for COVID-19 clinical research', 'volume': '20', 'year': '2020', 'journal-title': 'Lancet Infect. Dis.'}, { 'issue': '2', 'key': '10.1016/j.ajcnut.2024.06.016_bib14', 'article-title': 'Rasch analysis of the WURSS-21 dimensional validation and assessment of ' 'invariance', 'volume': '3', 'author': 'Brown', 'year': '2016', 'journal-title': 'J.\xa0Lung Pulm. Respir. Res.'}, { 'issue': '10', 'key': '10.1016/j.ajcnut.2024.06.016_bib15', 'doi-asserted-by': 'crossref', 'first-page': '1727', 'DOI': '10.1007/s11136-011-9903-x', 'article-title': 'Development and preliminary testing of the new five-level version of ' 'EQ-5D (EQ-5D-5L)', 'volume': '20', 'author': 'Herdman', 'year': '2011', 'journal-title': 'Qual. Life Res.'}, { 'issue': '32', 'key': '10.1016/j.ajcnut.2024.06.016_bib17', 'doi-asserted-by': 'crossref', 'first-page': 'E901', 'DOI': '10.1503/cmaj.200077', 'article-title': 'Development of the Instrument to assess the Credibility of Effect ' 'Modification Analyses (ICEMAN) in randomized controlled trials and ' 'meta-analyses', 'volume': '192', 'author': 'Schandelmaier', 'year': '2020', 'journal-title': 'CMAJ'}, { 'issue': '2', 'key': '10.1016/j.ajcnut.2024.06.016_bib18', 'first-page': '131', 'article-title': 'Utility of biochemical markers in predicting severe COVID-19: ' 'experience from a tertiary hospital in South India', 'volume': '33', 'author': 'Shenoy', 'year': '2022', 'journal-title': 'EJIFCC'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib19', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/20503121221108613', 'article-title': 'Potential role of biochemical markers in the prognosis of COVID-19 ' 'patients', 'volume': '10', 'author': 'Niraula', 'year': '2022', 'journal-title': 'SAGE Open Med'}, { 'issue': '13', 'key': '10.1016/j.ajcnut.2024.06.016_bib20', 'doi-asserted-by': 'crossref', 'first-page': '1066', 'DOI': '10.1001/jama.2023.3651', 'article-title': 'Heterogeneous treatment effects of therapeutic-dose heparin in patients ' 'hospitalized for COVID-19', 'volume': '329', 'author': 'Goligher', 'year': '2023', 'journal-title': 'JAMA'}, { 'issue': '1', 'key': '10.1016/j.ajcnut.2024.06.016_bib21', 'doi-asserted-by': 'crossref', 'first-page': '6570', 'DOI': '10.1038/s41598-023-33425-3', 'article-title': 'Causal Bayesian machine learning to assess treatment effect ' 'heterogeneity by dexamethasone dose for patients with COVID-19 and ' 'severe hypoxemia', 'volume': '13', 'author': 'Blette', 'year': '2023', 'journal-title': 'Sci. Rep.'}, { 'key': '10.1016/j.ajcnut.2024.06.016_bib22', 'doi-asserted-by': 'crossref', 'first-page': '93', 'DOI': '10.1016/j.bbi.2021.12.020', 'article-title': 'Fatigue and cognitive impairment in post-COVID-19 syndrome: a ' 'systematic review and meta-analysis', 'volume': '101', 'author': 'Ceban', 'year': '2022', 'journal-title': 'Brain Behav Immun'}], 'container-title': 'The American Journal of Clinical Nutrition', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0002916524005884?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0002916524005884?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2024, 8, 15]], 'date-time': '2024-08-15T19:49:19Z', 'timestamp': 1723751359000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0002916524005884'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 8]]}, 'references-count': 21, 'alternative-id': ['S0002916524005884'], 'URL': 'http://dx.doi.org/10.1016/j.ajcnut.2024.06.016', 'relation': {}, 'ISSN': ['0002-9165'], 'subject': [], 'container-title-short': 'The American Journal of Clinical Nutrition', 'published': {'date-parts': [[2024, 8]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Effect of spirulina on risk of hospitalization among patients with COVID-19: ' 'the TOGETHER randomized trial', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'The American Journal of Clinical Nutrition', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ajcnut.2024.06.016', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2024 Published by Elsevier Inc. on behalf of American Society for Nutrition.', 'name': 'copyright', 'label': 'Copyright'}]}
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit